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1. Introduction 
Metabolomics, the large-scale analysis of metabolites generated in metabolic pathways, has 
recently joined with “omics” integration studies (Tan et al., 2008;Martinez-Pinna et al., 
2010;Gehlenborg et al., 2010;Kint et al., 2010;Vlaanderen et al., 2010). In addition to metabolite 
profiling characteristic to metabolomics, metabonomics describes the wide spectrum of 
metabolites changing under certain conditions, such as disease, interventions and functional 
gene changes. Since these two terms (metabolomics and metabonomics) used interchangeably 
in literature (Mishur and Rea, 2011), in future discussion we will use only metabolomics for 
describing both quantitative metabolic profiling and changes in response to stimulus. 
Biochemically, metabolomics is the ultimate endpoint measurement of biological events and 
capturing the influences of nutrition, environmental influences, responses to pharmaceuticals, 
and many more. The history of metabolomics starts with the pioneering work of Horning who 
in the early 1960s applied gas chromatography (GC) for the metabolites profiling in urine 
(SWEELEY and Horning, 1960;Horning and VANDENHEUVEL, 1963). A few years later 
Pauling et al. expanded application of GC for metabolites analysis in both urine and breath 
(Pauling et al., 1971). Current advancements in bioanalytical instrumentations in combination 
with sample preparation techniques enables metabolomics studies virtually in all kinds of 
biological tissues and fluids. Ultimately clinical application of metabolic profiling became an 
important clinical tool in diagnosis and screening for inherited metabolic disorders (IMD), a 
group of over 200 single gene disorders.  
The vital progress of metabolomics usually occurs when new instrumentation or technique 
appears. Various state of the art techniques have been applied to metabolomics studies, 
including: nuclear magnetic resonance (NMR) spectroscopy (Reo, 2002;Ward et al., 
2007;Jordan and Cheng, 2007;Serkova et al., 2007;Duarte et al., 2009;Maher et al., 2009;Sofia et 
al., 2011), magnetic resonance imaging (MRI) (Elias et al., 2008;De Leon-Rodriguez et al., 
2009), infrared spectroscopy (IR) (Singh and Sinclair, 2007;Shaw et al., 2009;Corte et al., 2010), 
gas chromatography mass spectrometry (GC-MS) (Styczynski et al., 2007;Xu et al., 2009;Lin et 
al., 2010;Dehaven et al., 2010;Carroll et al., 2010;Tsugawa et al., 2011), capillary 
electrophoresis-MS (Lee et al., 2007;Soga, 2007;Lapainis et al., 2009;Barbas et al., 2011;Britz-
McKibbin, 2011) and HPLC-MS (Chen et al., 2007;Lu et al., 2008;Llorach et al., 2009;Gika and 
Theodoridis, 2011;Bajad and Shulaev, 2011) . Current metabolomics and metabolic profiling 
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studies rely almost exclusively on 1H NMR, GC-MS and LC-MS due to the technological 
maturity of these instrumentations. 
Although the concept of the application of NMR to metabolomics studies dates back to early 
nineteen eighties (Nicholson et al., 1983a;Nicholson et al., 1983b;Bales et al., 1984), Nicholson 
and colleagues laid the foundation of the contemporary NMR based metabolomics in 1999 
(Nicholson et al., 1999). In this elegant study, a wide range of biochemical, clinical and 
toxicological problems were addressed using a high resolution NMR based matabolomics 
approach. Nowadays NMR (mainly 1H NMR) is widely used for metabolomics studies. 
NMR has the following advantages in the metabolic studies: (i) sample preparation for 
NMR is much simplified; (ii) NMR is non-invasive and non-destructive so that the sample 
could be used in subsequent analysis by an alternative technique; (iii) the data is easily 
quantified and highly reproducible (Zhang et al., 2010); and (iv) various NMR spectral 
libraries are available for metabolites identifications, such as Human Metabolome Database 
(HMDB), the Madison Metabolomics Consortium Database (MMCD), the Biological 
Magnetic Resonance Data Bank (BMRB), the Magnetic Resonance Metabolomics Database or 
the Chenomx Database and either open source or publicly unavailable software tools (e.g. 
Analysis of MIXtures (AMIX) program, MetaboMiner, and rNMR which also permits to 
quantify the metabolites) (Malet-Martino et al., 2011). However, the low sensitivity of NMR 
analysis limits its application in metabolomics research. Recent effort has been put on 
improving the sensitivity of NMR by improving Larmor frequency, decreasing probe 
diameter and reducing noise (Malet-Martino et al., 2011).  
GC-MS technique has been seen as a traditional and standard approach for metabolomics 
studies because of its high separation ability, high sensitivity and easy analyte identification.  
Typical GC column has a length of 10 to 100 meters with the theoretical plate number of 
1,000 to 1000,000. This enables the GC-MS to analyze very complex biological samples.  The 
high sensitivity of the GC-MS allows metabolomics profiling of a complex mixture with a 
small volume of sample injection (1 μl) into GC-MS.  Most compounds can be detected at 1 
pmol or lower levels by GC-MS. Many public spectral libraries are available for electron-
impact (EI) GC-MS. The available libraries can save huge amount of work and time to 
identify the metabolites. The national institute of standardization and technology  mass 
spectral library (NIST 11) contains 243,893 carefully evaluated spectra of 212,961 unique 
compounds, with identifications, nearly all with chemical structures. Other available GC-MS 
libraries are Fiehn libraries for GC-quadrupole mass spectrometers from Agilent, and for 
GC-TOF mass spectrometers from Leco. These libraries are collected using EI mass 
spectrometers that combined with GC. Since only volatile compounds can be analyzed by 
GC-MS, therefore GC-MS data only covers part of metabolites from biological samples 
although some nonvolatile metabolites could become more volatile after derivatization.  
Notwithstanding the specific strengths of those different methodologies, the unique role of 
tandem mass spectrometry in metabolomics research is indisputable. Tandem mass 
spectrometry for metabolomics study has the following merits: (i) the high sensitivity of 
tandem mass spectrometry provides more information on trace amounts of metabolites; (ii) 
specific mass scan features of tandem mass spectrometry, such as precursor ion scan, neutral 
loss scan and multiple reaction monitoring scan, can simplify ion chromatograms. The 
application of liquid chromatography-coupled tandem mass spectrometry has 
revolutionized not only metabolic profiling of inherited metabolic disorders (IMD) but also 
the entire metabolic research, particularly the allied field of metabolomics.  
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In turn, recent advances in metabolomics have aided major discoveries made in several 
areas, including the identification of new metabolites and biomarkers of different diseases in 
both animal models and humans. In addition, metabolomics has been utilized in the 
investigation of metabolic pathways, biomarker identifications and molecular interactions 
and regulations. More recently, in combination with stable isotope technology, 
metabolomics has been successfully used for the identification of new metabolic pathways 
and the quantification of metabolic fluxes. Because of the objective to profile thousands or 
more metabolites in complex biological samples, untargeted metabolomics research requires 
a very elegant methodology or multiple combined methodologies.  In this chapter we will 
focus on our recent metabolomics studies by LC-MS/MS as well as some seminal literature 
as an introduction to the current applications of tandem mass spectrometry in metabolomics 
research.   
2. Targeted and untargeted metabolite profiling with tandem mass 
spectrometry 
The tandem mass spectrometry is a vital technique in identifying and quantifying different 
metabolites. We will use our recent work on lipid and folate metabolism as examples to 
highlight the unique role of tandem mass spectrometry in both targeted and untargeted 
metabolite profiling. Briefly, the targeted metabolomics experiment with tandem mass 
spectrometry measures defined ion transitions from known metabolites. The untargeted 
metabolomics experiment records all ions within a certain mass range, including the ions 
belonging to structurally novel metabolites (Vinayavekhin and Saghatelian, 2010).   
As a part of our research on lipid metabolism we applied tandem mass spectrometry to the 
analysis of different acyl-CoA derivatives.  Acyl-CoAs are intermediates in both fatty acid 
oxidation and synthesis. Acyl-CoAs are also formed during metabolism of some drugs 
containing carboxyl groups and therefore they can be used to track the metabolic pathways 
of several drugs. Structurally acyl-CoAs belong to a class of a large number of diverse 
compounds that have coenzyme A part and different acyl moieties. Despite the difference in 
acyl groups, all acyl-CoAs are catabolized through two distinct oxidation pathways in 
mitochondria and peroxisomes. Mitochondrial beta oxidation is the primary pathway of 
fatty acid oxidation that produces energy. Each cycle of mitochondrial beta oxidation 
generates enoyl-CoA, 3-hydroxyacyl-CoA and 3-ketoacyl-CoA intermediates before losing 
one acetyl-CoA. In contrast to mitochondrial oxidation, peroxisomal fatty acid oxidation can 
operate relatively independent of the cellular energy demand. This characterizes 
peroxisomal fatty acid oxidation as the pathway that eliminates poorly metabolized 
compounds, including the spillover of fatty acids and drug metabolites. Peroxisomal 
oxidation is primarily responsible for chain shortenings of very-long-chain fatty acids, 
methyl-branched fatty acids and dicarboxylic acids. Except the first step, all other steps in 
peroxisomal oxidation are very similar. The first and rate limiting step in peroxisomal beta 
oxidation is catalyzed by acyl-CoA oxidase utilizing molecular oxygen with the production 
of hydrogen peroxide. In this step, instead of ATP formation, the energy produced is 
dissipated as heat. The acetyl-CoA generated in peroxisomes is transferred into 
mitochondria for complete oxidation to CO2. The concentrations of acyl-CoAs formed in 
these metabolic pathways are quite different, some acyl-CoAs can reach 50-100 nmol/g, 
some of them are only 0.1-1 nmol/g (Gu et al., 2010;Harris et al., 2011). Therefore, acyl-CoA 
analysis is a challenge to the method development. Tandem mass spectrometry offers 
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several unique capacities for the acyl-CoA analysis. First of all, multiple reaction monitoring 
(MRM) has high sensitivity to acyl-CoA, because acyl-CoA containing multiple nitrogen 
atoms has very good ionization yield in positive electrospray ionization (ESI) mass 
spectrometry. Second, the collision induced dissociation (CID) of all acyl-CoA derivatives in 
tandem mass spectrometry generate the the common fragments at m/z 428 and 261 derived 
from coenzyme A moiety. Third, all acyl-CoA molecules in tandem mass spectrometry has 
the same neutral loss of 507. Most importantly, the neutral loss of 507 is the most abundant 
daughter ion for most of acyl-CoAs.  
2.1 Untargeted metabolites profile by tandem mass spectrometry 
The tandem mass spectrometer is designed for sensitive quantification of analytes. To 
quantify an analyte by tandem mass spectrometer, some compound information and 
parameters including precursor ion, daughter ion, declustering potential, and collision 
energy etc., should be known and optimized first. All these seem to determine that tandem 
mass spectrometer is only used for targeted metabolomics analysis. However, tandem mass 
spectrometry provides additional features that can be applied to untargeted metabolomics 
studies. Two types of tandem mass spectrometric untargeted metabolic profiling approaches 
are introduced here. The first one is the precursor ion scan that profiles all the metabolites 
having the same fragment.  The second approach is MRM scan that is basically similar to 
neutral loss scan.  
2.1.1 Precursor ion scan  
Tandem mass spectrometric characteristics of the acyl-CoA molecules can be used for the 
comprehensive analysis of fatty acid oxidation intermediates. The typical fragmentation of 
acyl-CoA is shown in Fig 1. As a survey analysis of all CoA derivatives, we developed acyl-
CoA precursor ion scan method using fragment at either 428 or 261 (Dalluge et al., 2002). 
Application of tandem mass spectrometry for discovery of new metabolites, including 
phospho-hydroxyacyl-CoA derivatives will be discussed in detail in section 3. The precursor 
ion scan is extremely helpful for this type of untargeted metabolite profiling because it 
profoundly filters out interferences by focusing on the metabolites that gives specific 
daughter ion(s).  
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Fig. 1. The acyl-CoA structure and typical fragmentation pattern in positive ESI.  
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The applications of precursor ion scan to profile metabolites have been reported by others 
(Millington et al., 1989;Wen et al., 2008;Millington and Stevens, 2011). Acylcarnitines that are 
from their corresponding acyl-CoAs are used for diagnostic test for inherited disorders of 
fatty acid and branched-chain amino acid catabolism. Millington et al. used precursor ion 
scan mode to profile acylcarnitines in plasma and whole blood using acylcarnitine methyl 
esters typical fragment ion at m/z 99 (CH2-CH=CH-COOCH3, positive ion) (Millington et 
al., 1989;Millington et al., 2011). In addition to qualitative profiling, precursor ion scan was 
also used for acylcarnitines quantiation by adding deuterium labeled acyl-carnitines in their 
work. Another fragment (m/z 85, CH2-CH=CH-COOH, positive ion) of acylcarnitine butyl 
esters was chosen for precursor ion scan to profile acylcarnitines in blood. Ten common 
acylcarnitines and 40 rare acylcarnitines were detected in defined mutant mice (Rolinski et 
al., 2000). Wen et al. screened unknown glutathione conjugate by negative precursor ion 
scan using fragment m/z 272 that corresponds to deprotonated -glutamyl-dehydroalanyl-
glycine originating from the glutathione moiety. The new metabolite, 2-hydroxy-3-
(glutathione-S-yl)-deschloro-meclofenamic acid, from meclofenamic acid was found by this 
method (Wen et al., 2008).   
2.1.2 MRM scan  
The advantage of MRM scan is its high sensitivity suitable for targeted quantification 
purposes. To establish a method in MRM mode one needs to obtain both the precursor and 
daughter ions information. This requires direct infusion of standard (precursor) compound 
into mass spectrometer and optimization of ionization and fragmentation parameters. Here 
we present our strategy to perform non-targeted analysis of acyl-CoA metabolites by MRM. 
As it is mentioned earlier, all acyl-CoAs have a neutral loss of 507 in tandem mass 
spectrometry (Fig 1). In addition, the mass of most endogenous acyl-CoA molecules ranges 
from 767 (non-esterified free CoA) to 1117 (C24 acyl-CoA, the largest physiological CoA 
derivative). For the comprehensive analysis of all acyl-CoA one can set the precursor ion 
scan from 768 ([M+H]+ for free CoA) to 1118 ([M+H]+ for C24 acyl-CoA), and their 
corresponding daughter ions’ m/z values are their precursor ions’ m/z data minus 507 at 
positive ESI. Therefore, MRM scan is programmed based on the neutral loss. However, 
MRM mode is more sensitive than neutral loss scan mode.  
After validation this MRM method with known acyl-CoAs, we performed a non-targeted 
acyl-CoA profiling from the isolated rat liver perfused with levulinic acid (4-ketopentanoic 
acid) (Harris et al., 2011). “Head-to-head” comparison of acyl-CoA profiles with the sham 
liver tissue enabled identification of the following acyl-CoA metabolites in the rat livers 
perfused with levulinic acid: levulinyl-CoA, 4-hydroxypentanoyl-CoA; 4-
phosphopentanoyl-CoA, 3-hydroxypentanaoyl-CoA, 3-ketopentanoyl-CoA, 4-hydroxy-2-
pentenoyl-CoA, 4-keto-2-pentenoyl-CoA, 3,4-dihydroxypentanoyl-CoA, 4-keto-3-hydroxy-
pentanoyl-CoA, 3-keto-4-hydroxypentanoyl-CoA and 3,4-diketopentanoyl-CoA. With such 
detailed acyl-CoA metabolites profile information, we can deduce three parallel catabolic 
pathways of levulinic acid in rat livers (Harris et al., 2011). Pathway A is the 
phosphorylation of 4-hydroxypentanoyl-CoA to form 4-phosphopentanoyl-CoA followed 
by isomerization to form 3-hyroxypentanoyl-CoA. The latter compound is a regular beta 
oxidation intermediate that can be further oxidized completely to form acetyl-CoA and 
propionyl-CoA. In pathway B, levulinic acid is reduced to 4-hydroxypentanoic acid and 
activated to 4-hydroxypentanoyl-CoA. The latter intermediate is cleaved to form lactyl-CoA 
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and acetyl-CoA via one cycle of beta oxidation. In pathway C, levulinic acid can be directly 
activated to form levulinyl-CoA that is further metabolized to 3,4-diketopentanoyl-CoA. 
Partial enzymatic reduction of this metabolite generates 3-keto-4-hydroxypentanoyl-CoA.  
Further degradation of 3-Keto-4-hydroxypentanoyl-CoA forms lactyl-CoA and acetyl-CoA 
(Harris et al., 2011).  Some of these intermediates are in small amount. For example, 4-Keto-
2-petanoyl-CoA is approximately 500 fold less than acetyl-CoA. Therefore, only a sensitive 
method utilizing the state-of-the-art technique like tandem mass spectrometry can identify 
such small quantities of these intermediates. 
2.2 Targeted metabolic profiling of ceramide species by tandem mass spectrometry 
Recently we utilized LC-MS/MS for the simultaneous profiling and quantification of 
different ceramide species in biological samples. Ceramides represent a class of compounds 
characterized with acyl group attached to amino group of sphingosine backbone.  The 
carbon number before the name, such as C14-ceramide for N-myrystyl-sphyngosine, 
specifies fatty acyl chain length. The fatty acids with chain length of C14-C26 are most 
common ceramide species existing in nature, although ceramides with shorter (C10, C12) 
and longer (C30) chains are also found.  
Ceramides play an important role in insulin resistance, cell signaling, cell differentiation, 
proliferation and apoptosis and serve as a precursor for many other sphingolipids (Hannun 
and Obeid, 2008;Kewalramani et al., 2010). Interestingly, ceramide and distinct ceramide 
metabolites have different and sometimes opposing functions in cell survival and apoptosis, 
glucose uptake and insulin resistance (Fig.2). Particularly, it is known that ceramide causes 
apoptosis and inhibits insulin signaling while sphingosine-1-phosphate increases 
intracellular glucose uptake and inhibits apoptic pathways through the activation of Akt.  
Because of these opposing effects ceramide/sphigosine-1-phosphate rheostat notion was 
formulated (Hannun et al., 2008).  
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Fig. 2. Role of ceramide and its metabolites in cell signaling. 
Although it is not known how the structure of individual ceramide species defines their 
physiological functions, it has been shown that ceramide containing specific fatty acids are 
generated in response to certain stimuli, underscoring the structure/function relationship 
for different ceramide species (Pewzner-Jung et al., 2006). For example, it is known that C16 
and C24 ceramide species are involved in cell death (Osawa et al., 2005), while C18 ceramide 
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inhibits cell growth (Koybasi et al., 2004). Investigation of the physiological function of 
distinct ceramides and their metabolites requires an accurate and sensitive method for their 
quantification in biological samples. Ceramides were analyzed by an enzymatic 
diacylglycerol kinase assay (Preiss et al., 1987),  by high performance liquid chromatography 
(HPLC) (Yano et al., 1998), and GC-MS analysis after derivatization (Tserng and Griffin, 
2003). However, these methods are labor intensive and time consuming. Although, some of 
these approaches may be used to analyze total ceramide or fatty acid moiety of ceramide, 
they do not provide information on individual ceramide species.  In addition, these methods 
generate discrepant results on ceramide levels in different biological samples (Turinsky et 
al., 1990;Yamaguchi et al., 2004).  The tandem mass spectrometry offers several advantages 
for the analysis of ceramides and their metabolites. The MS/MS mode enables high 
specificity of identification of the structurally related isomeric and isobaric complex 
compounds through the precursor/product relationship of ionized molecular and fragment 
ions.  Monitoring of selected precursor and daughter ions in MRM mode improves the 
sensitivity of the analysis.  A wide dynamic range of tandem mass spectrometry allows 
analysis of both low and high abundant ceramides and their metabolites in a single run.  
However, structural similarities, wide range biological levels of related sphingolipids and 
different physico-chemical properties (solubility, ionization) of ceramides and metabolites 
requires very careful selection of extraction methods, internal standards, instrumentation 
and mass spectrometric  parameters.   
Sphingolipids, including ceramides, are easily ionized and they produce several product 
ions characteristic for the backbone and fatty acids attached to the backbone. Most of the 
basic and complex sphingolipids form (M+H)+ and (M+H-H2O)+ positive ions, while 
phosphorylated sphinglipids also form negative (M-H)– ions in negative ESI mode. Recently 
lipidomic studies have used ESI-MS/MS technologies to analyze ceramides and related 
sphingolipids in biological samples (Schmelzer et al., 2007;Sullards et al., 2007).  
We have optimized and validated a reverse-phase liquid chromatography coupled ESI-
MS/MS technique for the simultaneous measurement of multiple ceramide species in 
different biological matrices (Kasumov et al., 2010). The method of analysis of tissue samples 
is based on Bligh and Dyer extraction (BLIGH and DYER, 1959), reverse-phase HPLC 
separation and MRM of ceramides. Preparation of plasma samples also requires isolation of 
sphingolipids by silica gel column chromatography prior to LC-ESI-MS/MS analysis. The 
limits of detection and quantification are in a range of 5-50 pg/ml for distinct ceramides.  
The method is reliable for inter-assay and intra-assay precision, accuracy and linearity. The 
separation and quantification of several endogenous long-chain and very-long-chain 
ceramides using two non-physiological odd chain ceramide (C17 and C25) as internal 
standards is achieved on a C8 reverse-phase column in less than 5 min during a single 21 
min chromatographic run. This method took advantage of the formation of m/z 264.3 
daughter ion representing the sphingosine backbone of ceramide (Fig. 3).  
To perform the survey analysis of different subspecies a scan of precursor ions was 
performed over a wide range of collision energies (10-65 eV) in a triple quadrupole tandem 
mass spectrometry. The MRM method was composed based on existing species in biological 
samples. The following transitions were selected for sensitive and selective analysis of 
biological ceramide species: 482.3/264.3 (C12:0), 510.3/264.3 (C14:0), 538.3/264.3 (C16:0), 
552.3/264.3 (C17:0), 564.3/264.3 (C18:1), 566.3/264.3 (C18:0), 592.6/264.3 (C20:1), 
594.6/264.3 (C20:0), 620.6/264.3 (C22:1), 622.6/264.3 (C22:0), 648.6/264.3 (C24:1), 
650.6/264.3 (C24:0), 676.6/264.3 (C26:1) and 678.6/264.3 (C26:0). In addition, the following 
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transitions were used for non-physiological internal standards: 552.3/264.3 (C17:0) and 
664.6/264.3 (C25:0). 
 
Fig. 3. Structure and fragmentation of ceramide, ceramide-1-phosphate and sphingosine-1-
phosphate with m/z 264.3 as the most abundant product ion during collision induced 
ionization. 
The technique was applied to quantify distinct ceramide species and metabolites in different 
rat tissues and in human plasma. Using this analytical technique we demonstrated that 
plasma and muscle ceramides are increased in obese subjects with type 2 diabetes and are 
associated with reduced insulin sensitivity (Haus et al., 2009).  This technique was extended 
for the quantification of ceramide metabolites ceramide-1-phosphate and sphingosine-1-
phosphate which utilized 380.3/264.3, 618.7/264.3 and 366.3/250.3 transitions for the 
sphingosine-1-phosphate and ceramide-1-phosphate and C17-sphingosine-1-phosphate 
(internal standard), respectively (Fig. 3). This method also could be applied to the analysis of 
other sphingolipids without significant modification.   
2.3 Targeted folate derivatives quantitation by tandem mass spectrometry 
Another good example of the application of tandem mass spectrometry for metabolite 
profiling is folate analysis. Folate is a water-soluble vitamin (B9), which plays a key role in 
the methylation cycle and in DNA biosynthesis. Folate deficiency has been implicated in 
hyperhomocysteinemia, which results in an increased risk of cardiovascular disease and 
dementia, and in neural tube defects. The folate analysis is challenging because of the 
complexity of folate derivatives in biological samples (see Fig 4) (Zhang et al., 2003;Zhang 
et al., 2005).  Different substitutes (R, Fig 4)) and various glutamate units account for the 
most of the structural diversity of folate derivatives. It is especially challenging for the 
most methods to differentiate such large number of folate derivatives. The classical gold 
method for folate analysis is a microbiological method that analyzes bacterial growth 
dependent on the available amount of folate (Koontz et al., 2005). Although 
microbiological method for folate analysis is very sensitive, it suffers from being not 
reproducible. In addition, only the total amount of folate (but not individual species) is 
measured by microbiological method.   
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Fig. 4. The structure of folate derivatives with different substituent and different number of 
glutamate. 
Tandem mass spectrometry has the unique capacity to differentiate the compounds as long 
as they have different masses of precursor ions and/or product ions. Mono-glutamate 
folates have different precursor ion and product ion masses, poly-glutamate folates have the 
same product ion as their corresponding mono-glutamate folate product ion with different 
precursor ion masses. For example:  precursor/product transitions for 5-
methyltetrahydrofolate mono-glutamate, 5-methyltetrahydrofolate di-glutamate, 5-
methyltetrahydrofolate tri-glutamate, 5-methyltetrahydrofolate tetra-glutamate, 5-
methyltetrahydrofolate penta-glutamate and 5-methyltetrahydrofolate hexa-glutamate are 
460/313, 589/313, 718/313, 847/313, 976/313 and 1105/313, respectively. Folate molecules 
with different number of glutamate have the following tandem mass spectrometric 
characteristics: (i) each additional glutamate has an additional 129 mass unit increase at the 
m/z of the precursor ion, (ii) they all have the same product ion.   
Antifolates are among the first anti-microbial agents invented. Clinical resistance to anti-
folates has been mainly attributed to mutations that alter the structure or the expression of 
enzymes involved in de novo folate synthesis. Our recent study showed that the deficiency of 
5,10-methenyltetrahydrofolate synthase was found to be hyper susceptible to anti-folate 
agents. We applied the tandem mass spectrometry technique to measure folates in the 
Mycobacterium smegmatis with the mutation of 5,10-methenyltetrahydrofolate synthase. The 
folate tandem mass spectrometry method is briefly summarized here. A Thermo Scientific 
Hypersil GOLD C18 column (150 × 2.1 mm), protected by a guard column (Hypersil GOLD 
C18 5 µm, 10 × 2.1 mm) was used to separate folates by applying gradient elution of two 
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mobile phases. Mobile phase A is 98% H2O with 2% acetonitrile containing 0.1% formic acid 
and mobile phase B is 98% acetonitrile with 2% H2O containing 0.1% formic acid. The 
starting eluent was 98% A / 2% B. Mobile phase B was linearly increased to 30% in 15 
minutes, then further increased to 90% in 2 minutes. The mobile B was kept at 90% for 4 
minutes and then adjusted to initial condition. The column was re-equilibrated at initial 
condition for 10 minutes before the next injection. The column oven and auto sampler were 
kept at 35 and 4C, respectively. The 4000 Qtrap mass spectrometer (AB Sciex, Foster City, 
CA) source parameters are set as follows: Turbo ion-spray source at 600 C, gas 1: 60 psi, gas 
2: 70 psi, curtain gas at 30 psi.  The mono-glutamate folate mass transitions and compound 
parameters are shown in Table 1. Poly-glutamate folate parent m/z is 129 more for one 
additional glutamate but with the same product ion m/z as the one corresponding to mono-
glutamate folate. Profiling of the folate derivatives showed that mono-glutamate folates had 
no change compared to the wild type Mycobacterium smegmatis, but dramatically decreased 
poly-glutamate 5-formyltetrahydrofolate, which indicates the important physiological role 
of poly-glutamate 5-formyltetrahydrofolate in the folate metabolism (Ogwang et al., 2011).  
 
Folates 
Parent 
m/z  
Product 
m/z  
CE 
(V)  
DP (V) EP (V) 
CXP 
(V) 
Folate  442.1 295.0 27 75 10 10 
Dihydrofolate 444.1 178.0 27 70 10 10 
Tetrahydrofolate 446.1 299.1 20 76 10 10 
5,10-methenyltetrahydroflate  456.1 412.1 31 60 10 10 
5,10-methylenetetrahydrofolate  458.1 311.1 23 70 10 10 
5-methyltetrahydrofolate  460.1 313.1 25 60 10 10 
5/10-formyltetrahydrofolate  474.1 327.1 20 71 10 10 
Table 1. Mono-glutamate folate compound parameters and mass transitions in tandem mass 
spectrometry. 
3. New metabolite discovery by tandem mass spectrometry 
Identification of new metabolites is a challenge due to (i) the complexity of biological 
samples, and (ii) the fact that novel metabolites usually have no reference compound or 
existing library data. In addition, it is difficult to characterize compound identities based on 
molecular mass alone. In this section we will show how tandem mass spectrometry can 
provide more fragmentation information to help elucidating the structure of molecules. In 
addition we will examine how high resolution tandem mass spectrometry confirms the 
hypothesized molecule and fragment formula. 
Tandem mass spectrometry provides information on the fragmentation, which is critical in 
the identification of new unknown metabolites. For example, the identity of 4-
phosphopentanoyl-CoA, a metabolite of 4-hydroxypentanoic acid, is deduced by careful 
analyzing its fragmentation pattern in positive ionization mode of tandem mass 
spectrometry (Zhang et al., 2009;Sadhukhan et al., 2010). 4-Phosphopentanoyl-CoA (m/z 
948) is 80 mass unit heavier than 4-hydroxypentanoyl-CoA (m/z=868). This suggests a 
possible phosphorylation. In addition, 4-phosphopentanoyl-CoA has fragments with m/z of 
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441, 428, 343, 312, 261, 214 and 160. The m/z at 428 and 261 confirms that this unknown 
compound is an acyl-CoA.  The neutral loss of 507 from precursor ion (m/z=948) yields a 
fragment ion at m/z=441. As we discussed earlier, neutral loss of 507 fragmentation pattern 
is one of the acyl-CoA characteristics in positive ionization tandem mass spectrometry. Two 
steps of further fragmentation with a loss of 98 (one phosphoric acid) from fragments of 441 
and 312 to form daughter ions 343 and 214. This fragmentation pattern confirms the 
phosphorylation at 4-hydroxy group of 4-hydroxypentanoyl-CoA. The detailed scheme of 
fragmentation and chemical structures of fragment ions are shown in Fig 5. 
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Fig. 5. Fragmentation pathway of 4-phosphopentanoyl-CoA in tandem mass spectrometry. 
This example demonstrates the utility of product ion scan for identification of new 
metabolites. However, the success rate of determining metabolite structures based on MRM 
fragmentation data will ultimately depend on the experience of the individual investigator, 
the availability of in house or public fragmentation libraries of the same or similar class of 
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compounds, and the chemical nature of the metabolite itself, in terms of fragmentation 
information produced. Compared to EI NIST library data, LC-tandem mass spectrometry 
library is still at initial stage.  
Single or triple quadrupole mass spectrometers usually have relatively low mass resolution 
(unit mass resolution).  However, instruments such as time of flight (TOF), Orbitrap™, and 
Fourier transform ion cyclotron resonance mass spectrometry (FTICR) have high mass 
resolution of up to 100,000 (at m/z 400). The high mass resolution and mass accuracy can 
ensure mass error less than 3 ppm (Metz et al., 2007). From such accurate mass 
measurements, candidate empirical formula of detected species may be determined. One or 
more empirical formula may be generated for each metabolite. The high resolution tandem 
mass spectrometry provides additional information on the identity of unknown metabolites. 
The excellent example of using accurate mass spectrometer is the identification of the 
unknown metabolite (4-phosphopentanoyl-CoA) from 4-hydroxypentanoic acid catabolism 
(see section 2.1). The exact mass of 4-phosphopentanoyl-CoA and its three fragments (A, B 
and C) were measured by high resolution mass spectrometry to obtain their exact masses. 
Table 2 represents both measured exact mass and the theoretical mass, calculated from 
chemical formula of hypothesized metabolite (4-phosphopentanoyl-CoA), and its three 
fragments (m/z values of fragments are 441, 428 and 343).  The differences between 
measured exact mass and theoretical values are all lower than 0.5 ppm. Thus, the exact mass 
measurements by high resolution tandem mass spectrometry confirmed the hypothesized 
chemical formula.   
 
 
Hypothesized 
formula 
Theoretical 
mass 
Measured 
mass 
Difference 
(ppm) 
[4-Phospho-pentanoyl-
CoA-H]+ 
C26H46N7O21P4S 948.141803 948.14141 0.41449 
Fragment A C16H30N2O8PS 441.146051 441.14612 0.15641 
Fragment B C10H16N5O10P2 428.037244 428.03732 0.17755 
Fragment C C16H27N2O4S 343.169154 343.16905 0.30306 
Table 2. The exact mass of 4-phosphopentanoyl-CoA and its three fragments. 
4. Identification of biomarkers for specific diseases 
A biomarker is a substance that is objectively measured for indication of the presence of an 
abnormal condition in a patient and allows disease progression and/or therapeutic response 
to be monitored. In this section we will review selected examples of the applications of 
tandem mass spectrometry to the discoveries of metabolic biomarkers characteristic of 
several pathological conditions.   
Recently Sreekumar et al. found that sarcosine was significantly increased in the invasive 
prostate cancer cell line (Sreekumar et al., 2009). If this finding is true, the sarcosine analysis 
in urine sample has significance in prostate cancer diagnosis. However, the relation between 
sarcosine and prostate cancer are still subject to dispute (Pavlou and Diamandis, 
2009;Jentzmik et al., 2010;Struys et al., 2010). Soga et al. identified ophthalmic acid as a new 
oxidative stress biomarker in mice treated with acetaminophen (Soga et al., 2006). 
Ophthalmic acid, L--glutamyl-L--aminobutyrylglycine, is a tripeptide analogue of 
glutathione in which the cysteine group is replaced by L-2-aminobutyrate. Glutathione is a 
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major cellular anti-oxidant and is involved in the second phase detoxification of several 
drugs, including acetaminophen. As expected, acetaminophen treated mice had a sudden 
drop in hepatic glutathione levels which was paralleled with the appearance of an unknown 
compound with m/z of 290 in positive ionization mass spectrometry. The product ion 
spectrum of this unknown metabolite was comparable with that of the product ion spectra 
of glutathione but with 17.957 differences in mass. Based on these results authors deduced 
that the SH group of the cysteine residue of glutathione was replaced by a methyl (CH3) 
group. This non polar side chain corresponds to 2-aminobutyrate, the side product of de 
novo cysteine synthesis in transsulfuration pathway. The replacement of cysteine residue by 
2-aminobutyrate in glutathione molecule forms ophthalmic acid. The reduced glutathione 
and cysteine are decreased in conditions associated with oxidative stress. Sequestration of 
glutathione and cysteine induces both cysteine and glutathione synthesis. Stimulated 
cysteine production generates 2-aminobutyrate while increased demand for glutathione 
induces glycine cysteine synthase that utilizes 2-aminobutyric acid when cysteine levels are 
below the Km of this enzyme. The mechanism of ophthalmate formation in conditions 
associated with oxidative stress is outlined in Fig 6. Abbas et al. found increased 
ophthalmate formation in the rabbit liver with implanted tumor which was paralleled with 
the reduced glutathione synthesis (Abbas et al., 2011).   
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Fig. 6. The relationship between ophthalmate and glutathione concentration changes in the 
oxidative stress.   
Recently the tandem mass spectrometry assisted biomarker discovery was applied to 
predict the development of diabetes (Wang et al., 2011). Among 2422 normoglycemic 
individuals followed by 12 years, 201 developed diabetes.  In these cases, 5 branched-chain 
and aromatic amino acids, i.e. isoleucine, leucine, valine, tyrosine and phenylalanine, were 
found to have significant associations with future development of diabetes. The risk of 
future diabetes was elevated at least 4-fold in subjects with high plasma amino acid 
concentrations.  
5. Tandem mass spectrometry combined with the mass isotopomer analysis 
in metabolomics research 
Because of the natural existence of low proportions of heavy 13C (1.10%), 2H (0.015%), 15N 
(0.37%), and 18O (0.20%) isotopes, biological molecules are identified by the number and 
position(s) of these isotopes. Mass isotopomers differ by the number of heavy atoms in their 
molecules, resulting in different molecular weights. In mass spectrometric jargon, they are 
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referred to as M, M1, M2, …, Mn (Brunengraber et al., 1997).  The application of stable 
isotope labeled compounds in metabolomics research is not only useful for the identification 
and the characterization of metabolic pathways but also provides a powerful strategy to 
measure metabolite fluxes, i.e. the synthesis and degradation rates of those metabolites.  In 
this section, we will briefly discuss the application of 13C and 2H isotope containing 
compounds to the quantification of metabolic fluxes through fatty acid oxidation and 
protein synthesis.  
First we consider 2H2O-metabolic labeling based approach utilizing tandem mass 
spectrometry for protein turnover studies (Kasumov et al., 2011).  Proteins exist in a 
dynamic state of equilibrium with their surrounding environment. The net static protein 
expression is determined by changes in a protein turnover, i.e. both synthesis and 
degradation. It is difficult to detect small changes in protein abundance, whereas the 
changes in the turnover rates are easily measurable. Advances in isotopic tracer methods 
and improvements in subcellular isolation methods have enabled studies of various 
protein fractions, i.e. total membrane, mitochondrial, sarcoplasmic or cytosolic proteins. 
However, understanding the pathologies related to the regulations of protein metabolism 
requires methods for studying the synthesis of an individual protein. Classical protein 
turnover studies relied on precursor-product relationships and involved the 
administration of a labeled amino acid. These methods require a long-term oral 
consumption or intravenous infusion of labeled amino acids, isolation mixed or 
individual proteins at different time points and degradation of proteins to individual 
amino acids. After column purification amino acids are derivatized and their labeling 
measured by GC-MS. This is a labor-intensive protocol that requires extensive purification 
of proteins and amino acids and often associated with contaminations. Recently we used a 
high resolution ion-trap tandem mass spectrometry, i.e.  FTICR MS, to study the protein 
synthesis. Predictable fragmentation pattern of peptides in an ion-trap as a result of CID 
allows de novo sequencing of a protein. Particularly, the cleavage at the C-N amide (along 
with Cα-C and N-Cα bonds) in an ion-trap MS results in the mass difference between 
consecutive ions within a series corresponding to the specific amino acid and allows 
deduction of the peptide sequence. In addition, the high resolution of the ICR detector 
allows an accurate mass isotopomer analysis of a selected peptide. We took advantage of 
these capacities of the high resolution ion-trap tandem mass spectrometry for the 
measurement of 2H-enrichment of protein-bound amino acids in our 2H2O-based protein 
turnover studies. Oral administration of 2H2O (a safe, non-radioactive isotope) in drinking 
water  results in a rapid steady state labeling of body water in free living organisms. 2H2O 
rapidly labels proteogenic amino acids, indicating that amino acids transfer to protein 
chain is a rate liming step in a protein biosynthesis (Rachdaoui et al., 2009). Incorporation 
of multiple copies of 2H from 2H2O to non essential amino acids results in the 
amplification of the isotopic enrichment in a product and enhances the measurements of 
their labeling. A time-domain stepwise fragmentation of a peptide in a selective reaction 
monitoring mode with the zoom scans of the precursor peptide and two of its consecutive 
fragments allows measurement of the 2H-labeling of a protein bound amino acids. Thus, 
instead of purification of an individual protein and following degradation to amino acids 
for labeling measurement, this technique allows the measurement of an individual 
protein-bound amino acid even in a complex mixture of proteins. This approach was 
applied to measure the turnover rate constant of albumin in rats with the total body water 
enrichment of ~2.65% (Kasumov et al., 2011). Fig 7 demonstrates the time dependent 
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labeling observed in daughter ions derived from tryptic albumin peptide LVQEVTDFAK. 
The difference between the labeling of two consecutive fragment ions, i.e. QEVTDFAK vs 
EVTDFAK represents the labeling of peptide-bound glutamine. As expected, glutamine 
with several exchangeable hydrogen atoms incorporates a substantial quantity of 
deuterium. Thus, measurement of a peptide-bound amino acid labeling allows a reliable 
estimation of albumin kinetic parameters, i.e. the fractional synthesis rate (k= 0.37±0.05 
day-1) and the half-life (t1/2 = 1.71 day) when compared with data obtained using the 
precursor ion (k= 0.36±0.06 day-1 and t1/2 = 1.76 day). Assessment of the labeling of 
individual protein-bound amino acids via tandem mass spectrometry is especially 
important when calculating the kinetics of a protein with shorter half-life. The major 
assumption for a protein turnover study is that amino acids precursor labeling reaches the 
steady state much faster than that of their incorporation into proteins. Therefore, 
simultaneous measurements of labeling of proteolytic peptides and a peptide-bound 
amino acid allow both the validation of this assumption and the calculation the kinetic 
parameters. 
 
 
Fig. 7. Time course labeling of measured tryptic peptides QEVTDFAK and EVTDFAK and 
calculated labeling of peptide-bound glutamine (Q). 
The second example highlights the utilization of the mass isotopomer analysis coupled 
metabolomics in the metabolic pathway discovery. In this case metabolomics in combination 
with stable isotopes is used to dissect 4-hydroxy-2-trans-nonenal (HNE) catabolism. HNE is 
a reactive unsaturated aldehyde derived from lipid peroxidation. HNE modified proteins, 
lipids and DNAs are the pathogenic factors. The detoxification of HNE is mainly via 
glutathione conjugation or reduction to 1,4-dihydroxynonene. HNE oxidation to 4-
hydroxynonanoic acid is another major detoxification pathway. We identified two parallel 
catabolic pathways of 4-hydroxynonanoic acid in rat liver (Zhang et al., 2009;Sadhukhan et 
al., 2010). Two pathways are shown in Fig 8. The first round beta oxidation is the same for 
both pathways. The difference between pathway A and B starts from carbon 3 and 4 of 4-
hydroxynonanoic acid. With a specifically isotope positional labeled 4-hydroxynonanoic 
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acid, i.e. [3,4-13C2]-4-hydroxynonanoic acid, one can track the catabolic pathways of 4-
hydroxynonante. In addition, quantification of the isotopically labeled products also allows 
calculating the relative rate of two pathways. [3,4-13C2]-4-Hydroxynonanoic acid is activated 
to M2 4-hydroxynonanoyl-CoA in the rat liver. In pathway A, M2 4-hydroxynonanoyl-CoA 
is isomerized to M2 3-hydroxynonanoyl-CoA that undergoes regular beta oxidations. 
Continuous beta oxidations of 3-hydroxynonanoyl-CoA complete HNE degradation in the 
pathway A and generate one M2 acetyl-CoA. In the pathway B, 4-hydroxynonanoyl-CoA 
splits one acetyl-CoA through first round beta oxidation to form M2 2-hydroxyheptanoyl-
CoA. M2 2-hydroxyheptanoyl-CoA is alpha oxidized to form M1 formic acid and M1 
hexanoyl-CoA. M1 hexanoyl-CoA is further beta oxidized to form one M1 acetyl-CoA. 
Therefore, M1 and M2 acetyl-CoA are generated through pathway B and A, respectively. 
One can analyze mass isotopomer enrichment of acetyl-CoA and determine the rate of two 
pathways based on M2 acetyl-CoA/M1 acetyl-CoA ratio if M1 and M2 acetyl-CoA are 
exclusively from pathway B and A. 
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Fig. 8. The formation of M2 and M1 acetyl-CoA from two parallel catabolic pathways (A and 
B) of [3,4-13C2]-4-hydroxynonanoyl-CoA (M2 4-hydroxynonanoyl-CoA). 
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In both examples discussed above tandem mass spectrometry was used to measure the 
labeling of the fragment ions of the analytes. The mass isotopomer analysis of fragment ions, 
rather than whole molecule has following advantages: (i) the lower natural mass isotopomer 
distribution background of fragment improves the accuracy of mass isotopomer 
measurement, and (ii) the fragment mass isotopomer analysis provides positional labeling 
information. The positional mass isotope labeling measured by tandem mass spectrometry 
provides additional information on metabolic pathways and enables flux calculation that 
enriches metabolomics studies (Jeffrey et al., 2002;Antoniewicz et al., 2007;Kiefer et al., 
2007;Choi and Antoniewicz, 2011).  
6. Conclusions  
Tandem mass spectrometry is a sensitive and accurate technique that has been applied for 
targeted metabolites quantification. Traditional metabolomics investigation was limited by the 
sensitivity of analytical methods.  Therefore the application of tandem mass spectrometry in 
metaboliomics study has emerged recently. This chapter mainly discussed the major 
applications of tandem mass spectrometry in recent metabolic studies: targeted metabolites 
quantification, untargeted analysis of a class of metabolites, biomarker assay, unknown 
metabolites identification and mass isotopomer analysis coupled tandem mass spectrometry. 
More insightful metabolic findings have been achieved with the help of sensitive tandem mass 
spectrometric technique. Current tandem mass spectrometry is limited to the targeted or semi 
un-targeted metabolic profiling. The single cell metabolism study is a challenging task because 
of the limitations related to the sensitivity of all existing methods. Achieving these goals in 
metabolomics studies requires the following improvements: (i) a more general un-targeted 
metabolomics methodology using tandem mass spectrometry is needed, (ii) a standardized 
tandem mass spectrometric condition is needed so that a public tandem mass spectrometric 
library could be generated, and (iii) further improvement of sensitivity. The future 
advancement of tandem mass spectrometry and bioinformatics tools should address these and 
other related issues in the metabolomics field.  
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